Discovery of a Series of Indazole TRPA1 Antagonists.

about

Discovery of a Series of Indazole TRPA1 Antagonists.

Item

http://www.wikidata.org/entity/Q50938174

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Discovery of a Series of Indazole TRPA1 Antagonists.

@en

Discovery of a Series of Indazole TRPA1 Antagonists.

@nl

type

Item

label

Discovery of a Series of Indazole TRPA1 Antagonists.

@en

Discovery of a Series of Indazole TRPA1 Antagonists.

@nl

prefLabel

Discovery of a Series of Indazole TRPA1 Antagonists.

@en

Discovery of a Series of Indazole TRPA1 Antagonists.

@nl

P1476

Discovery of a Series of Indazole TRPA1 Antagonists.

@en

P2093

Aaron C Gerlach

http://www.w3.org/2001/XMLSchema#string

Brett Antonio

http://www.w3.org/2001/XMLSchema#string

Brian E Marron

http://www.w3.org/2001/XMLSchema#string

Christopher W West

http://www.w3.org/2001/XMLSchema#string

David C Pryde

http://www.w3.org/2001/XMLSchema#string

George Amato

http://www.w3.org/2001/XMLSchema#string

Jamie Turner

http://www.w3.org/2001/XMLSchema#string

John H Mahoney

http://www.w3.org/2001/XMLSchema#string

Joseph S Warmus

http://www.w3.org/2001/XMLSchema#string

Karen Padilla

http://www.w3.org/2001/XMLSchema#string

P2860

A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome

Structure of the TRPA1 ion channel suggests regulatory mechanisms

Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine

TRPA1 as a drug target--promise and challenges

The pore-domain of TRPA1 mediates the inhibitory effect of the antagonist 6-methyl-5-(2-(trifluoromethyl)phenyl)-1H-indazole

Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1

Transient receptor potential (TRP) channels: a clinical perspective

Transient receptor potential ankyrin 1 receptor activation in vitro and in vivo by pro-tussive agents: GRC 17536 as a promising anti-tussive therapeutic.

TRP channels as therapeutic targets in airway disorders: a patent review.

Development of a new permeability assay using low-efflux MDCKII cells.

P304

666-671

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.7B00140

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28626530

http://www.w3.org/2001/XMLSchema#string

P932

5467201

http://www.w3.org/2001/XMLSchema#string